Chelsea Therapeutics (Nasdaq: CHTP) stock soared 31.30% to $6.59 today (Thursday) after agreeing to be acquired by Danish pharmaceutical company H. Lundbeck in a deal valued at $658 million.
Terms of the deal are related to the performance of Chelsea's key drug Northera.